FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39116411000001105: Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1673641000001118 Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1673651000001115 Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has specific active ingredient Indacaterol acetate true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has specific active ingredient Indacaterol acetate false Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Inhalation true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has dispensed dose form Conventional release powder for inhalation true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has specific active ingredient Mometasone furoate true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Indacaterol false Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route powderinhalation.inhalation ontology form and route true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Is a Indacaterol + Mometasone true Inferred relationship Existential restriction modifier
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device 30 capsule Has VMP True Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Inferred relationship Existential restriction modifier
Atectura Breezhaler 125micrograms/260micrograms inhalation powder capsules with device (Sandoz Ltd) Is a True Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start